Perbak Capital Partners’s Sotera Health SHC Stock Holding History

Perbak Capital Partners’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,363	Closed	-$407K	–	210
2026 Q1	$407K	Buy	+28,363	New	+$471K	0.1%	221

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Perbak Capital Partners's SHC Position: Q2 2026 in Review

Perbak Capital Partners sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 28,363 shares — an estimated $407K sold.

Perbak Capital Partners first reported a position in SHC in Q1 2026 and held it in 1 quarter. The position peaked at $407K in Q1 2026. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

Perbak Capital Partners reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 28,363 Sotera Health shares in Q2 2026, an estimated $407K.
Perbak Capital Partners first reported a position in Sotera Health in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Sotera Health position peaked at $407K in Q1 2026.
316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.